24Prescription for certain narcotic substances to be issued only on authority of Secretary

24 Prescription for certain narcotic substances to be issued only on authority of Secretary

[Regulation 24 Amended by S.R. 2025, No. 8, Applied:12 Mar 2025] A medical practitioner or nurse practitioner must not, without the authority of the Secretary, issue a prescription for, or supply to a patient, the following narcotic substances, namely:

(a) amphetamine;

(b) cannabis;

(c) dexamphetamine;

(d) dextromoramide;

(da) [Regulation 24 Amended by S.R. 2022, No. 45, Applied:13 Jul 2022] esketamine;

(e) fentanyl, except in the case of a patient with cancer;

(f) hydromorphone;

(g) ketamine;

(h) lisdexamfetamine;

(i) methadone;

(j) methylamphetamine;

(k) methylphenidate;

(l) nabiximols;

(la) [Regulation 24 Amended by S.R. 2023, No. 96, Applied:27 Dec 2023] N,α-dimethyl-3,4-(methylenedioxy)methamphetamine (MDMA);

(m) pethidine;

(n) [Regulation 24 Amended by S.R. 2022, No. 45, Applied:13 Jul 2022] phenmetrazine;

(na) [Regulation 24 Amended by S.R. 2023, No. 96, Applied:27 Dec 2023] psilocybine;

(o) [Regulation 24 Amended by S.R. 2022, No. 45, Applied:13 Jul 2022] tetrahydrocannabinol.

Penalty:  Fine not exceeding 10 penalty units.